EBLN3P and neoplasm: Recent studies have revealed that lncRNAs are new diagnostic and prognostic biomarkers for various tumors including LUAD [9,11–15,43,44], and a high expression of the lncRNA EBLN3P is associated with tumor progression [16,17,45].